<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Atrial Fibrillation Blog&#187; Study</title>
	<atom:link href="http://atrialfibrillationblog.com/category/study/feed/" rel="self" type="application/rss+xml" />
	<link>http://atrialfibrillationblog.com</link>
	<description>From StopAfib.org - For Afib Patients, By Afib Patients</description>
	<lastBuildDate>Fri, 03 Feb 2012 07:55:56 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Update on Atrial Fibrillation Stroke Prevention — Video interview with Dr. Daniel Singer of Harvard</title>
		<link>http://atrialfibrillationblog.com/update-on-atrial-fibrillation-stroke-prevention-video-interview-with-dr-daniel-singer-of-harvard/</link>
		<comments>http://atrialfibrillationblog.com/update-on-atrial-fibrillation-stroke-prevention-video-interview-with-dr-daniel-singer-of-harvard/#comments</comments>
		<pubDate>Wed, 25 Jan 2012 13:11:20 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Audio/Video]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Resources]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib stroke]]></category>
		<category><![CDATA[anticoagulants]]></category>
		<category><![CDATA[apixaban]]></category>
		<category><![CDATA[atrial fibrillation stroke prevention]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[dabigatran]]></category>
		<category><![CDATA[Dr Daniel Singer]]></category>
		<category><![CDATA[edoxaban]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[video]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1223</guid>
		<description><![CDATA[In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/update-on-atrial-fibrillation-stroke-prevention-video-interview-with-dr-daniel-singer-of-harvard/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Boston Atrial Fibrillation Symposium 2012 Recap and Notes – Guest Posts by Dr. John Mandrola</title>
		<link>http://atrialfibrillationblog.com/boston-atrial-fibrillation-symposium-2012-recap-and-notes-guest-posts-by-dr-john-mandrola/</link>
		<comments>http://atrialfibrillationblog.com/boston-atrial-fibrillation-symposium-2012-recap-and-notes-guest-posts-by-dr-john-mandrola/#comments</comments>
		<pubDate>Thu, 19 Jan 2012 18:13:43 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[Sleep Apnea]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib stroke]]></category>
		<category><![CDATA[atrial fibrillation stroke prevention]]></category>
		<category><![CDATA[focal beats]]></category>
		<category><![CDATA[pulmonary vein isolation]]></category>
		<category><![CDATA[reconnection]]></category>
		<category><![CDATA[rotors]]></category>
		<category><![CDATA[surgical ablation]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1176</guid>
		<description><![CDATA[Dr. John Mandrola, a cardiac electrophysiologist in Louisville, Kentucky, who blogs at Dr. John M, live-blogged the 2012 Boston Atrial Fibrillation Symposium. He has given us permission to reprint his blog posts for the afib community. You will find them here: Recap of Boston Atrial Fibrillation Symposium 2012 – Guest Posts by Dr. John Mandrola [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/boston-atrial-fibrillation-symposium-2012-recap-and-notes-guest-posts-by-dr-john-mandrola/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Mini Maze Procedure May Be a Good Option for Atrial Fibrillation Patients Who Have Failed Catheter Ablation</title>
		<link>http://atrialfibrillationblog.com/mini-maze-procedure-may-be-a-good-option-for-atrial-fibrillation-patients-who-have-failed-catheter-ablation/</link>
		<comments>http://atrialfibrillationblog.com/mini-maze-procedure-may-be-a-good-option-for-atrial-fibrillation-patients-who-have-failed-catheter-ablation/#comments</comments>
		<pubDate>Mon, 09 Jan 2012 13:55:16 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Cure]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[FAST clinical trial]]></category>
		<category><![CDATA[mini maze procedure]]></category>
		<category><![CDATA[minimally invasive surgery]]></category>
		<category><![CDATA[minimally invasive surgical ablation]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1149</guid>
		<description><![CDATA[Results from FAST, the first-ever randomized trial to compare the effectiveness of minimally invasive surgical ablation (also called the mini maze procedure) for atrial fibrillation and catheter ablation for afib, were presented at the recent American Heart Association meeting. The FAST study enrolled patients who had failed a previous catheter ablation procedure. The minimally invasive [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/mini-maze-procedure-may-be-a-good-option-for-atrial-fibrillation-patients-who-have-failed-catheter-ablation/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>FDA Approves Bipolar Radiofrequency Surgical Ablation System for Persistent Atrial Fibrillation</title>
		<link>http://atrialfibrillationblog.com/fda-approves-bipolar-radiofrequency-surgical-ablation-system-for-persistent-atrial-fibrillation/</link>
		<comments>http://atrialfibrillationblog.com/fda-approves-bipolar-radiofrequency-surgical-ablation-system-for-persistent-atrial-fibrillation/#comments</comments>
		<pubDate>Tue, 03 Jan 2012 13:07:41 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Cure]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[ABLATE clinical trial]]></category>
		<category><![CDATA[AtriCure Synergy bipolar radiofrequency clamp]]></category>
		<category><![CDATA[FDA approval]]></category>
		<category><![CDATA[longstanding persistent atrial fibrillation]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1141</guid>
		<description><![CDATA[The Food and Drug Administration (FDA) approved the AtriCure Synergy Ablation System for the treatment of persistent and longstanding persistent atrial fibrillation in patients undergoing another heart surgery. The Synergy bipolar radiofrequency clamp is the only surgical ablation device with FDA approval for afib treatment. Learn more: FDA Advisory Panel Recommends, and FDA Approves, Bipolar [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/fda-approves-bipolar-radiofrequency-surgical-ablation-system-for-persistent-atrial-fibrillation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>High Success Rates for Atrial Fibrillation Focal and Rotor Catheter Ablations — Video with Dr. Sanjiv Narayan</title>
		<link>http://atrialfibrillationblog.com/high-success-rates-for-atrial-fibrillation-focal-and-rotor-catheter-ablations-%e2%80%94-video-with-dr-sanjiv-narayan/</link>
		<comments>http://atrialfibrillationblog.com/high-success-rates-for-atrial-fibrillation-focal-and-rotor-catheter-ablations-%e2%80%94-video-with-dr-sanjiv-narayan/#comments</comments>
		<pubDate>Fri, 09 Dec 2011 13:44:49 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Audio/Video]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[atrial fibrillation catheter ablation]]></category>
		<category><![CDATA[Dr. Sanjiv Narayan]]></category>
		<category><![CDATA[FIRM trial]]></category>
		<category><![CDATA[focal ablation]]></category>
		<category><![CDATA[rotor ablation]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1107</guid>
		<description><![CDATA[At the American Heart Association Scientific Sessions 2011, Dr. Sanjiv Narayan presented the high success rate of the FIRM trial of focal and rotor catheter ablation for atrial fibrillation. Watch the video at: Atrial Fibrillation Focal and Rotor Catheter Ablations Show High Success Rates — Video Interview with Dr. Sanjiv Narayan About the FIRM Trial]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/high-success-rates-for-atrial-fibrillation-focal-and-rotor-catheter-ablations-%e2%80%94-video-with-dr-sanjiv-narayan/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Apixaban (Eliquis) prevents more atrial fibrillation strokes than warfarin — March FDA approval expected</title>
		<link>http://atrialfibrillationblog.com/apixaban-eliquis-prevents-more-atrial-fibrillation-strokes-than-warfarin-%e2%80%94-march-fda-approval-expected/</link>
		<comments>http://atrialfibrillationblog.com/apixaban-eliquis-prevents-more-atrial-fibrillation-strokes-than-warfarin-%e2%80%94-march-fda-approval-expected/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 18:00:10 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib strokes]]></category>
		<category><![CDATA[apixaban]]></category>
		<category><![CDATA[atrial fibrillation stroke prevention]]></category>
		<category><![CDATA[Eliquis]]></category>
		<category><![CDATA[stroke risk]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1100</guid>
		<description><![CDATA[A recent New England Journal of Medicine article reported on the results of the ARISTOTLE trial comparing the effectiveness of apixaban and warfarin for atrial fibrillation stroke prevention. Apixaban was shown to be superior to warfarin in preventing afib strokes. Learn more about the results of this trial at: Apixaban Superior to Warfarin for Atrial [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/apixaban-eliquis-prevents-more-atrial-fibrillation-strokes-than-warfarin-%e2%80%94-march-fda-approval-expected/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Women Have Different Atrial Fibrillation Ablation Results from Men — Video Interview with Dr. John Mandrola</title>
		<link>http://atrialfibrillationblog.com/women-have-different-atrial-fibrillation-ablation-results-from-men-%e2%80%94-video-interview-with-dr-john-mandrola/</link>
		<comments>http://atrialfibrillationblog.com/women-have-different-atrial-fibrillation-ablation-results-from-men-%e2%80%94-video-interview-with-dr-john-mandrola/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 13:09:38 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Audio/Video]]></category>
		<category><![CDATA[AV Node Ablation]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[atrial fibrillation ablation]]></category>
		<category><![CDATA[AV node ablation]]></category>
		<category><![CDATA[Dr. John Mandrola]]></category>
		<category><![CDATA[women]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1087</guid>
		<description><![CDATA[At the American Heart Association Scientific Sessions 2011, Dr. John Mandrola presented a poster on gender-specific results of atrial fibrillation ablation in a private practice setting. In this video interview with him about the poster, he mentioned that in his experience women appear to be more challenging to treat with atrial fibrillation ablation and do [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/women-have-different-atrial-fibrillation-ablation-results-from-men-%e2%80%94-video-interview-with-dr-john-mandrola/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Panel Says Bipolar Radiofrequency Surgical Ablation Effective for Persistent Atrial Fibrillation</title>
		<link>http://atrialfibrillationblog.com/fda-panel-says-bipolar-radiofrequency-surgical-ablation-effective-for-persistent-atrial-fibrillation/</link>
		<comments>http://atrialfibrillationblog.com/fda-panel-says-bipolar-radiofrequency-surgical-ablation-effective-for-persistent-atrial-fibrillation/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 13:01:15 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Cure]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[ABLATE clinical trial]]></category>
		<category><![CDATA[AtriCure Synergy bipolar radiofrequency clamp]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[longstanding persistent atrial fibrillation]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=924</guid>
		<description><![CDATA[An FDA advisory panel voted that the overall benefits outweighed the risks in afib ablations using the AtriCure Synergy bipolar radiofrequency clamp. This was based on the results of the ABLATE clinical trial for ablation of persistent or longstanding persistent atrial fibrillation during other heart surgery. The panel recommended that the FDA approve it, setting [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/fda-panel-says-bipolar-radiofrequency-surgical-ablation-effective-for-persistent-atrial-fibrillation/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>FDA Approves Alternative to Warfarin — Rivaroxaban (Xarelto) Approved for Atrial Fibrillation Stroke Prevention</title>
		<link>http://atrialfibrillationblog.com/fda-approves-alternative-to-warfarin-%e2%80%94-rivaroxaban-xarelto-approved-for-atrial-fibrillation-stroke-prevention/</link>
		<comments>http://atrialfibrillationblog.com/fda-approves-alternative-to-warfarin-%e2%80%94-rivaroxaban-xarelto-approved-for-atrial-fibrillation-stroke-prevention/#comments</comments>
		<pubDate>Mon, 07 Nov 2011 13:08:52 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib strokes]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[stroke risk]]></category>
		<category><![CDATA[warfarin]]></category>
		<category><![CDATA[Xarelto]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=920</guid>
		<description><![CDATA[The US Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those with non-valvular atrial fibrillation (afib unrelated to heart valve problems). Xarelto is now the second oral alternative to warfarin (Coumadin) and offers an option for those unable to take warfarin or dabigatran. Xarelto is the first once-a-day alternative to [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/fda-approves-alternative-to-warfarin-%e2%80%94-rivaroxaban-xarelto-approved-for-atrial-fibrillation-stroke-prevention/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>CHA2DS2-VASc or CHADS2 For Atrial Fibrillation Stroke Prevention? Should Aspirin Be Used? Video with Prof. Greg Lip</title>
		<link>http://atrialfibrillationblog.com/cha2ds2-vasc-or-chads2-for-atrial-fibrillation-stroke-prevention-should-aspirin-be-used-video-with-prof-greg-lip/</link>
		<comments>http://atrialfibrillationblog.com/cha2ds2-vasc-or-chads2-for-atrial-fibrillation-stroke-prevention-should-aspirin-be-used-video-with-prof-greg-lip/#comments</comments>
		<pubDate>Mon, 24 Oct 2011 12:12:21 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Audio/Video]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[CHA2DS2-VASc]]></category>
		<category><![CDATA[CHADS2]]></category>
		<category><![CDATA[Gregory Y. H. Lip MD]]></category>
		<category><![CDATA[stroke prevention]]></category>
		<category><![CDATA[video]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=897</guid>
		<description><![CDATA[In this important video interview at Venice Arrhythmias, Professor Gregory Lip discusses the importance of the CHA2DS2-VASc scoring tool for predicting atrial fibrillation stroke risk and why aspirin is not appropriate for preventing strokes. Watch the video at: Professor Gregory Lip Discusses CHA2DS2-VASc Tool for Predicting Stroke Risk in Atrial Fibrillation — Video]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/cha2ds2-vasc-or-chads2-for-atrial-fibrillation-stroke-prevention-should-aspirin-be-used-video-with-prof-greg-lip/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk: basic
Page Caching using disk: enhanced

Served from: atrialfibrillationblog.com @ 2012-02-07 15:58:42 -->
